FindTrial
Sign In

Develop a whole immune cell map based on single-cell sequencing to guide the precise evaluation of immune function and explore intervention targets in sepsis

Develop a whole immune cell map based on single-cell sequencing to guide the precise evaluation of immune function and explore intervention targets in sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068416
Enrollment
Unknown
Registered
2023-02-17
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

sepsis group:no
Healthy group:NO

Sponsors

Ningxia Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. Diagnosed with sepsis within 24h.

Exclusion criteria

Exclusion criteria: 1. Age <18 years old; 2. Malignancy; 3. Acquired immunodeficiency syndrome; 4. Autoimmune disease; 5. Receiving immunosuppressive therapy; 6. Withdrawal from the investigator.

Design outcomes

Primary

MeasureTime frame
Immune cell profiling;—

Secondary

MeasureTime frame
procalcitonin, PCT;hs-CRP;IL-6;IL-10;IFN-?;—

Countries

China

Contacts

Public ContactYang Xiaojun

Ningxia Medical University General Hospital

yxjicu@163.com+86 13895101220

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026